Citations per year, relative to Stephen C. Dragotakes Stephen C. Dragotakes (= 1×)
peers
Anna Perrone
Countries citing papers authored by Stephen C. Dragotakes
Since
Specialization
Citations
This map shows the geographic impact of Stephen C. Dragotakes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Dragotakes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Dragotakes more than expected).
Fields of papers citing papers by Stephen C. Dragotakes
This network shows the impact of papers produced by Stephen C. Dragotakes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Dragotakes. The network helps show where Stephen C. Dragotakes may publish in the future.
Co-authorship network of co-authors of Stephen C. Dragotakes
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. Dragotakes.
A scholar is included among the top collaborators of Stephen C. Dragotakes based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Stephen C. Dragotakes. Stephen C. Dragotakes is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
11 of 11 papers shown
1.
Dragotakes, Stephen C., et al.. (2025). The Nuclear Pharmacist’s Perspective. Journal of Nuclear Medicine Technology. 53(Supplement 1). 102S–109S.
2.
Schwarz, Sally W., Jeffrey P. Norenberg, Marc S. Berridge, et al.. (2012). The Future of USP Monographs for PET Drugs. Journal of Nuclear Medicine. 54(3). 472–475.4 indexed citations
3.
Bonab, Ali A., et al.. (2005). Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.. PubMed. 46(9). 1522–30.103 indexed citations
4.
Werner, Jens, Stephen C. Dragotakes, Carlos Fernández‐del Castillo, et al.. (1998). Technetium-99m-Labeled White Blood Cells. Annals of Surgery. 227(1). 86–94.49 indexed citations
5.
Babich, John W., Wendy Graham, Stephen C. Dragotakes, et al.. (1993). Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit.. PubMed. 34(12). 2176–81.56 indexed citations
6.
GRAHAM, W. A. G., et al.. (1993). Localization of indium-111-immunoglobulin G, technetium-99m-immunoglobulin G and indium-111-labeled white blood cells at sites of acute bacterial infection in rabbits.. PubMed. 34(11). 1975–9.14 indexed citations
7.
Rabito, C, et al.. (1993). Noninvasive, real-time monitoring of renal function: the ambulatory renal monitor.. PubMed. 34(2). 199–207.33 indexed citations
Callahan, Ronald J., et al.. (1986). A Multi-institutional In Vitro Evaluation of Commercial 99mTc Macroaggregated Albumin Kits. Journal of Nuclear Medicine Technology. 14(4). 206–209.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.